Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Camp Lejeune Water Contamination Law Delayed Once Again in U.S. Senate GOP Senators say they oppose unrelated spending in broader Veterans toxic substance exposure legsilation that includes Camp Lejeune water contamination bill. July 28, 2022 Irvin Jackson Add Your Comments New legislation that would provide veterans and family members with financial compensation for injuries caused by water contamination at Camp Lejeune Marine training base in North Carolina, as well as benefits associated with other toxic exposures during military service, has been temporarily blocked by a group of Republican Senators, including many who voted for the bill only a few weeks ago. The U.S. Senate previously voted 84-14 in June to pass the “Honoring Our PACT” Act, which is an expansive piece of legislation that would expand eligibility for VA healthcare benefits to more than 3.5 million veterans exposed to toxic burn pits and other chemicals, and also includes the Camp Lejeune Justice Act. On July 13, the U.S. House of Representatives passed an almost identical version of the Senate Camp Lejeune water contamination bill with overwhelming bipartisan support in a 342-88 vote, making only one change to remove a specific clause related to the tax treatment of certain income derived from contract buyouts of healthcare professionals as authorized by the act. The amended legislation was expected to quickly pass the U.S. Senate again, and President Biden has pledged to swiftly sign the bill into law. However, a group of GOP Senators have blocked the bill, voting against the end of a filibuster, including more than two dozen law makers who previously passed the same bill only a few weeks ago. On Wednesday, the only 55 U.S. Senators voted to end a filibuster on the Honoring Our PACT Act, falling short of required 60 votes. Senators Delay Justice and Benefits for U.S. Military Service Members The legislation has been a major part of President Biden’s agenda, and has received widespread support since it was introduced. However, the two law makers who originally sponsored the Camp Lejeune Justice Act late last year, Sen Thom Tillis (R-NC) and Sen. Richard Burr (R-NC) voted against ending the filibuster this week. One part of the bill would open a two year window for former military and family members to file water contamination lawsuits for injuries caused by toxic Camp Lejeune water between 1953 and 1987. Previously individuals exposed to the  were barred from obtaining benefits or any settlements, since the statute of limitations and statute of repose in North Carolina prevented claims by the time the water contamination was confirmed. More than one million Marines and their family members lived at Camp Lejeune between the early 1950s and late 1980s, and some estimates suggest that toxic chemicals in the water may be responsible for more than 50,000 cases of breast cancer, 28,000 cases of bladder cancer, and 24,000 cases of renal cancer, as well as thousands of cases involve Parkinson’s disease, birth defects and other health complications. Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Since there will only be a limited time to document and pursue claims once the law is enacted, lawyers have already started investigating potential Camp Lejeune water lawsuits in advance of the legislation’s final passage, and gathering information about individual injuries suffered, so that necessary experts can be retained. Samples of the Camp Lejeune water supply have identified multiple different volatile organic compounds (VOC) that posed a risk to individuals living or working on the base, including trichlorethylene (TCE), tetrachloroethylene (PCE), vinyl chloride (VC) and benzene. The U.S. Department of Veterans Affairs has previously established a list of certain conditions that are presumptively caused by the Camp Lejeune toxic water, including bladder cancer, kidney cancer, liver cancer, multiple myeloma, non-Hodgkin’s lymphoma, Parkinson’s disease, adult leukemia, aplastic anemia and other myelodysplastic syndrome. However, numerous additional injuries are believed to be related to the water and the VA has only covered claims for veterans, not their family members. Once the bill is signed into law, the U.S. government will not be able to raise the North Carolina statute of limitations or statute of repose as a defense in the Camp Lejeune water lawsuits, or assert qualified immunity to the claims. However, each individual plaintiff will still need to establish a causal relationship between their claimed injury and the toxins in Camp Lejeune water, which will require expert testimony and supporting evidence. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Camp Lejeune, Cancer, Congress, Military, North Carolina, Senate, Veteran, Water Contamination More Camp Lejeune Lawsuit Stories Camp Lejeune Settlement Update Outlines Plans To Resolve Water Contamination Lawsuits by End of 2025 March 26, 2025 Total Number of Camp Lejeune Injury Claims Drops to 480K, After De-Duplication Process: Report January 9, 2025 EPA Finalizes Ban on Chemicals Linked to Camp Lejeune Cancer Side Effects December 10, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCompanyThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Camp Lejeune Settlement Update Outlines Plans To Resolve Water Contamination Lawsuits by End of 2025 March 26, 2025
Total Number of Camp Lejeune Injury Claims Drops to 480K, After De-Duplication Process: Report January 9, 2025
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)